Literature DB >> 10579335

Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells.

T W Furlanetto1, L Q Nguyen, J L Jameson.   

Abstract

Goiter (increased thyroid gland size) is more prevalent in women than men, even in areas where iodine levels in the diet are sufficient. We investigated a possible role of estrogen on thyroid follicular cell growth using rat FRTL-5 thyroid follicular cells as a model. Estrogen receptor-alpha (ERalpha) messenger RNA was present in FRTL-5 cells using a RT-PCR assay and was confirmed by Western blot analysis. An estrogen-responsive reporter gene was transfected into FRTL-5 cells to test the functionality of the endogenous ERs. Estradiol increased the activity of the reporter gene, and the antagonist, ICI182780, inhibited ER-dependent transcription. To extend this analysis, we examined the effect of estradiol on FRTL-5 cell growth. Estradiol increased FRTL-5 cell growth in a time- and concentration-dependent manner in either the absence or presence of TSH. Because iodine is known to inhibit thyroid cell growth, the effect of estradiol on the expression of the sodium/iodide symporter (NIS) was assessed as a potential target of estrogen action. Estradiol blocked TSH-induced NIS expression, and treatment of cells with estradiol and ICI182780 restored TSH-induced NIS expression to normal levels. These data demonstrate that FRTL-5 cells contain functional ERs that enhance cell growth and inhibit expression of the NIS. The demonstration of a direct effect of estradiol on thyroid follicular cells raises the possibility that it may play a role in the sexually dimorphic prevalence of goiter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579335     DOI: 10.1210/endo.140.12.7197

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  39 in total

1.  Validation of reference genes for normalizing gene expression in real-time quantitative reverse transcription PCR in human thyroid cells in primary culture treated with progesterone and estradiol.

Authors:  Ana Paula Santin; Aline Francielle Damo Souza; Llma Simoni Brum; Tania Weber Furlanetto
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 2.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

Review 3.  Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.

Authors:  M Knobel
Journal:  J Endocrinol Invest       Date:  2015-09-21       Impact factor: 4.256

4.  3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Authors:  Shilpi Rajoria; Robert Suriano; Perminder Singh Parmar; Yushan Lisa Wilson; Uchechukwu Megwalu; Augustine Moscatello; H Leon Bradlow; Daniel W Sepkovic; Jan Geliebter; Stimson P Schantz; Raj K Tiwari
Journal:  Thyroid       Date:  2011-01-22       Impact factor: 6.568

5.  Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.

Authors:  T Kogai; J J Schultz; L S Johnson; M Huang; G A Brent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 6.  Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.

Authors:  Christine Spitzweg; John C Morris
Journal:  Mol Cell Endocrinol       Date:  2010-02-12       Impact factor: 4.102

7.  The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue.

Authors:  Hyun Jung Oh; June-Key Chung; Joo Hyun Kang; Won Jun Kang; Dong Young Noh; In Ae Park; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

8.  Common genetic variation in CYP1B1 is associated with concentrations of T₄, FT₃ and FT₄ in the sera of polycystic ovary syndrome patients.

Authors:  Shien Zou; Qing Sang; Huan Wang; Ruizhi Feng; Qiaoli Li; Xinzhi Zhao; Qinghe Xing; Li Jin; Lin He; Lei Wang
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

9.  Metastatic phenotype is regulated by estrogen in thyroid cells.

Authors:  Shilpi Rajoria; Robert Suriano; Arulkumaran Shanmugam; Yushan Lisa Wilson; Stimson P Schantz; Jan Geliebter; Raj K Tiwari
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

10.  Estradiol-mediated tumor neo-vascularization.

Authors:  Shilpi Rajoria; Robert Suriano; Yushan L Wilson; Andrea L George; Jan Geliebter; Stimson P Schantz; Raj K Tiwari
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.